ASMB - CIK 0001426800
The table below shows ASSEMBLY BIOSCIENCES, INC.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$41.09M | -$51.12M | $22.74M | -$84.46M | -$93.40M | -$62.96M |
| Capital expenditure | $66.00K | $28.00K | $255.00K | $102.00K | $3.10M | $470.00K |
| Investing cash flow | -$113.47M | $40.17M | -$69.14M | $90.64M | $26.52M | $68.07M |
| Dividends paid | - | - | - | - | - |
ASSEMBLY BIOSCIENCES, INC. reported operating cash flow of -$41.09M for fiscal year 2025. That is up 19.6% from -$51.12M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow declined from -$34.88M (FY 2016) to -$41.09M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | - | - | - | - | - | - |
| Financing cash flow | $174.67M | $29.45M | $13.82M | $614.00K | $53.06M | $7.60M |